Dudediligence.

Rocket Pharmaceuticals, Inc

RCKTNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$0.00Sep ’24$0.00Dec ’24$0.00Mar ’25$0.00Jun ’25$0.00Sep ’25$0.00Dec ’25$0.00Mar ’26$0.00Jun ’26
Net income, by quarter
−$66.7MSep ’24−$60.3MDec ’24−$61.3MMar ’25−$68.9MJun ’25−$50.3MSep ’25−$42.5MDec ’25−$47.6MMar ’26$123.2MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$0.00$0.00$0.00$0.00$0.00
Operating income−$167.2M−$224.3M−$259.7M−$273.2M−$231.7M
Net income−$169.1M−$221.9M−$245.6M−$258.7M−$223.1M
Operating cash flow−$121.2M−$178.1M−$194.9M−$209.7M−$190.0M
Free cash flow−$128.8M−$186.5M−$211.4M−$215.6M−$190.5M
Cash$232.7M$140.5M$55.9M$163.6M$77.6M
Shares outstanding64.5M79.1M90.3M106.5M108.3M